Gala Pharmaceutical, Inc. announced that it has completed construction of its cannabis testing facility in Long Beach, California. The company is currently in the process of ordering equipment and begin the initial steps towards ISO17025 accreditation. Gala Pharmaceutical is looking forward to capturing the lucrative southern California cannabis testing market. In 2018, California initiated new state testing requirements to help further increase quality and safety. As testing requirements become enforced over the coming year, consumers can further rely on their medical and recreational cannabis to be safe for consumption. The adoption and enforcement of these testing requirements will help build consumer trust and confidence in licensed cannabis goods and bring much needed revenue for the state of California. While many in the cannabis industry cited this as a hindrance to the growth and advancement of the market, Gala feels it is exactly in part what has, and will continue, to drive consumer adoption through increased confidence on the product, particularly as the state tax on cannabis goods has raised prices. Therefore, Gala Pharmaceutical plans to strategically position itself at the forefront of this movement by implementing testing procedures to produce accurate and reproducible results that both consumers and licensed cannabis companies can depend on. As testing requirements become enforced over the coming year, consumers can further rely on their medical and recreation marijuana to be safe for consumption. Gala Pharmaceutical plans to be at the forefront of this movement, implementing reliable and consistent testing of cannabis goods that consumers and licensed cannabis companies can rely on.